Radiology

Publishers Alliance Minimizing second cancer risk following radiotherapy: current perspectives

Minimizing second cancer risk following radiotherapy: current perspectives

[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.

Radiation and Your Patient Using genomic correlates of radiotoxicity to predict patient outcomes

Using genomic correlates of radiotoxicity to predict patient outcomes

Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.

Radiation and Your Patient Monitoring psychosocial function in radiotherapy

Monitoring psychosocial function in radiotherapy

Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.

Radiation and Your Patient High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.

Radiation and Your Patient A review of radiotherapy-induced hypopituitarism

A review of radiotherapy-induced hypopituitarism

Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.

Advisor Forum A career change to radiation oncology nursing

A career change to radiation oncology nursing

What is the best approach to learning more about the field of Radiation Oncology?

Advisor Forum Optimal dosing for TMZ: 1 hour prior to RT versus bedtime

Optimal dosing for TMZ: 1 hour prior to RT versus bedtime

Is there a difference in dosing (1 hour prior to radiotherapy vs bedtime) with temozolomide plus radiotherapy for glioblastoma multiforme?

Ask a Pharmacist Safety of combining imatinib and radiotherapy

Safety of combining imatinib and radiotherapy

Is combination therapy of imatinib (Gleevec) and radiotherapy safe?

Radiation and Your Patient Preventing radiotherapy-associated sexual dysfunction in prostate cancer

Preventing radiotherapy-associated sexual dysfunction in prostate cancer

Sexual dysfunction is a common and distressing side effect of prostate cancer treatment. Two new reports from randomized clinical trials offer mixed results for adjuvant pharmacotherapy intended to prevent erectile dysfunction in men undergoing radiotherapy for prostate cancer.

ONS Annual Congress 2014

Gabapentin benefits oropharyngeal cancer patients

ANAHEIM, CALIFORNIA—Among oropharyngeal patients receiving radiotherapy, gabapentin improved pain management and reduced weight loss, which potentially prevents the need for placement of a gastrostomy tube, according to a study presented at the Oncology Nursing Society (ONS) 39th Annual Congress.

Most commonly used treatment for prostate cancer is radiotherapy

A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.

Many patients with locally advanced breast cancer do not receive postmastectomy radiation

More than a third of women who should receive radiation subsequent to mastectomy are actually undergoing the recommended postmastectomy radiation therapy (PMRT), according to a new study.

Three genes are tied to radiation resistance in recurrent glioblastoma tumors

A new study has identified three genes that combined enable a lethal form of brain cancer to recur and progress after radiation therapy.

Novel radioguided surgery technique could help pinpoint cancer tissue

A novel radio-guided surgery technique could quickly and effectively identify residual cancer cells during brain tumor surgery, reducing radiation exposure for both patients and surgeons.

Some older patients with breast cancer can avoid postsurgery radiotherapy

Radiotherapy can be avoided by older women with breast cancer without a compromise to their safety, according to a recent study.

Exercise beneficial for patients with head and neck cancers undergoing radiation therapy

Exercise beneficial for patients with head and neck cancers undergoing radiation therapy

Significant benefits of exercise regimen in reducing the effect of percutaneous endoscopic gastrostomy placement on swallowing function for patients with head and neck cancer.

European researchers explore using patient-reported outcome tool to monitor radiotherapy side effects

Researchers have developed a tool to monitor the effects, including fatigue and inflammation, commonly associated with the radiotherapy used to treat lung cancer.

Radiation plus hormone therapy prolongs survival for older men with prostate cancer

The addition of radiation treatment to hormone therapy reduced more cancer deaths among older men locally advanced prostate cancer, compared to hormone therapy alone.

Aerobic exercise reduces fatigue in women undergoing radiotherapy for breast cancer

Aerobic exercise reduces fatigue in women undergoing radiotherapy for breast cancer

Findings in a quasi-experimental study of Taiwanese women with early-stage breast cancer showed the potential for exercise to reduce fatigue in women undergoing radiotherapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs